Pharmaceutical export is unlikely to respond to Japanese earthquake
Published: 2011-03-16 06:57:00
Updated: 2011-03-16 06:57:00
Korea will not benefit from Japan’s earthquake, while shares of domestic drugmakers such as CJ Cheil Jedang and Jeil Pharmaceutical are forecast to see gains, as growing demand for vaccines and antibiotics are expected to be on the increase.
“Although Japan was hit by the massive earthquake, J...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
